ArticleDiscover oncology2025
Construction of prognostic scoring model for ovarian cancer based on deep learning algorithm.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Ovarian cancer is one of the deadliest cancers of the female reproductive system, with poor prognosis, especially when diagnosed at an advanced stage. Accurate prognostic prediction and timely treatment are critical for improving patient outcomes. The aim of this study was to develop a prognostic prediction model for ovarian cancer based on pathological images. 158 In-house and 105 TCGA-OV pathological slides were processed with Macenko's algorithm for stain normalization and patch extraction (256 × 256 pixels). The CLAM framework was applied to construct a prognostic model validated via time-dependent ROC and survival analysis. The model achieved AUCs of 0.93 (internal) and 0.70 (external), demonstrating its potential for clinical translation. In addition, the prediction model was analysed in combination with patients' clinical characteristics and transcriptomic data. The results showed a significant prognostic difference between high and low risk groups. Our model can accurately predict the prognosis of ovarian cancer patients, which provides certain reference value for clinical diagnosis and treatment, especially when integrated with biomarkers like CA-125 for personalized risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.